Nasdaq & Dilution Is The Entire Ball Game Moving Forward >>> Christopher Moreau said his fellow Canadians are the primary reason the Algernon story has remained Upside | Down.
Therefore, there appears to be no way out for what came out of the CEO's mouth but to Uplist ASAP.
The CEO's own words suggest the company will remain a feckless company until such time as a move to Nasdaq.
Once there, the Algernon story may take on a life steered by a higher level of investment types in all important categories.
Meaning, the CEO can take his hand off the wheel - push autopilot and let the Nasdaq Capital Markets frame the narrative henceforth.
In the lean and meantime, the message out the gate with options could be one of confidence or incompetence.
Given DMT and IPF news awaits, pat on the back handouts out the gate as your 1st news release is definitely a head scratcher.
Ground Control (messaging) is a critical component to keeping the plane in the air.
Out of control dilution cannot be the strategy of the day moving forward.
What good is a Billion Dollar Market Cap if your shares have been diluted to the point each share is still under water for pre/post split shareholders?
If management comes out the gate with million share dilution post a punishing consolidation of shares, shareholders are likely toast for the long run or in the CEO’s words “I believe we will slowly get to the valuation we deserve for all of our research programs” on the Nasdaq.
As management will have proven they prefer to run around the bases backwards by taking homerun worthy narratives (like Bellus Health and GH Research) and turn them into complete strikeouts.
Bellus Health - One Trick Pony - Chronic Cough - Billion Dollar Market Cap
GH Research - One Trick Pony - DMT - Billion Dollar Market Cap
One would think the CEO has yet to figure out the “rocket science” being deployed by competitors.
Think Big To Accomplish Big Things.
Musk, Branson, Bezos.
Rare Air Thinkers.